These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17331851)

  • 21. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chemokine receptor CCR5 genetic polymorphism and expression in rheumatoid arthritis patients.
    Kohem CL; Brenol JC; Xavier RM; Bredemeier M; Brenol CV; Dedavid e Silva TL; de Castilhos Mello A; Cañedo AD; Neves AG; Chies JA
    Scand J Rheumatol; 2007; 36(5):359-64. PubMed ID: 17963165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single nucleotide polymorphism of CC chemokine ligand 5 promoter gene in recipients may predict the risk of chronic graft-versus-host disease and its severity after allogeneic transplantation.
    Kim DH; Jung HD; Lee NY; Sohn SK
    Transplantation; 2007 Oct; 84(7):917-25. PubMed ID: 17984846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and the role of CCR5Δ32 heterozygosity in disease progression in HIV positive patients in the Czech Republic.
    Sácká L; Hodek J; Machala L; Malý M; Weber J
    Epidemiol Mikrobiol Imunol; 2019; 68(3):138-143. PubMed ID: 31914779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis.
    Brajão de Oliveira K; Reiche EM; Kaminami Morimoto H; Pelegrinelli Fungaro MH; Estevão D; Pontello R; Franco Nasser T; Watanabe MA
    J Cutan Pathol; 2007 Jan; 34(1):27-32. PubMed ID: 17214851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The presence of functional CCR5 and EBV reactivation after allogeneic haematopoietic stem cell transplantation.
    Bogunia-Kubik K; Jaskula E; Lange A
    Bone Marrow Transplant; 2007 Jul; 40(2):145-50. PubMed ID: 17530006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV.
    Sullivan AD; Wigginton J; Kirschner D
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10214-9. PubMed ID: 11517319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No Association between the CCR5Δ32 Polymorphism and Sporadic Esophageal Cancer in Punjab, North-West India.
    Sambyal V; Manjari M; Sudan M; Uppal MS; Singh NR; Singh H; Guleria K
    Asian Pac J Cancer Prev; 2015; 16(10):4291-5. PubMed ID: 26028088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pacemaker therapy for early and late sinus node dysfunction in orthotopic heart transplant recipients: a single-center experience.
    Luebbert JJ; Lee FA; Rosenfeld LE
    Pacing Clin Electrophysiol; 2008 Sep; 31(9):1108-12. PubMed ID: 18834460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of heterozygous CCR5Δ32 deletion with survival in HIV-infection: A cohort study.
    Ruiz-Mateos E; Tarancon-Diez L; Alvarez-Rios AI; Dominguez-Molina B; Genebat M; Pulido I; Abad MA; Muñoz-Fernandez MA; Leal M
    Antiviral Res; 2018 Feb; 150():15-19. PubMed ID: 29221798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.
    Teixeira SL; Bastos FI; Hacker MA; Morgado MG
    Infect Genet Evol; 2009 Jul; 9(4):638-42. PubMed ID: 19460331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of CCR5Δ32 mutation in protecting patients with Schistosoma mansoni infection against hepatitis C viral infection or progression.
    El-Moamly AA; El-Sweify MA; Rashad RM; Abdalla EM; Ragheb MM; Awad MM
    Parasitol Res; 2013 Jul; 112(7):2745-52. PubMed ID: 23515570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
    HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in clinical profile and survival after heart transplantation according to prior heart disease.
    Agüero J; Almenar L; Martínez-Dolz L; Moro J; Izquierdo MT; Cano O; Salvador A
    Transplant Proc; 2007 Sep; 39(7):2350-2. PubMed ID: 17889185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility.
    Srivastava A; Pandey SN; Choudhuri G; Mittal B
    Scand J Immunol; 2008 May; 67(5):516-22. PubMed ID: 18405329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation.
    Munster JM; van der Bij W; Breukink MB; van der Steege G; Zuurman MW; Hepkema BG; Verschuuren EA; van Son WJ; Seelen MA
    Transplantation; 2008 Dec; 86(12):1857-63. PubMed ID: 19104434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common CCR 5 polymorphism in stroke: the CCR 5 delta32 polymorphism differentiates cardioembolism from other aetiologies of ischaemic cerebrovascular diseases.
    Kostulas N; Markaki I; Kostulas V; Hillert J; Kostulas K
    Scand J Immunol; 2009 Nov; 70(5):475-80. PubMed ID: 19874552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Frequency of CCR5del32 Mutation in Populations of Russians, Tatars and Bashkirs of Chelyabinsk Region, Russia.
    Govorovskaya I; Khromova E; Suslova T; Alexeev L; Kofiadi I
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):109-112. PubMed ID: 28083604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device.
    Bruggink AH; van Oosterhout MF; De Jonge N; Gmelig-Meyling FH; De Weger RA
    Transpl Immunol; 2008 Apr; 19(1):64-8. PubMed ID: 18346639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recipient genotype is a predictor of allograft cytokine expression and outcomes after pediatric cardiac transplantation.
    Auerbach SR; Manlhiot C; Reddy S; Kinnear C; Richmond ME; Gruber D; McCrindle BW; Deng L; Chen JM; Addonizio LJ; Chung WK; Mital S
    J Am Coll Cardiol; 2009 May; 53(20):1909-17. PubMed ID: 19442892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.